Home Supplements That Start With H Hordenine: What It Is, Potential Benefits, Recommended Use, Dosage Guidelines, and Risks

Hordenine: What It Is, Potential Benefits, Recommended Use, Dosage Guidelines, and Risks

25

Hordenine is a naturally occurring phenethylamine found in barley and a handful of desert cacti. In supplements, it is marketed for energy, focus, and fat-loss—claims that stem from its stimulant-like actions and lab data showing activity at dopamine D2 receptors. Human research remains sparse, but small kinetic studies and in-vitro work suggest rapid oral absorption, short plasma half-life (about an hour), and extensive sulfation and glucuronidation. Animal data point to anti-inflammatory effects at specific doses, while cell studies explore hair-follicle biology and pigmentation pathways. That said, there is no standardized therapeutic dose, and safety in long-term, everyday use has not been established. If you’re curious about hordenine, this guide lays out how it is thought to work, what the evidence actually shows, typical product forms, practical use scenarios, key risks, and who should avoid it—especially athletes who must comply with anti-doping rules.

Key Insights

  • May produce short-lived alertness via indirect sympathomimetic effects and dopamine D2 receptor activity.
  • No clinically established benefits for fat-loss or cognitive performance in healthy adults.
  • Human dosing is not established; research exposures range from ~0.05–0.1 mg/kg (dietary sources) to animal doses of 10–15 mg/kg.
  • Avoid if pregnant, breastfeeding, under 18, or if you have cardiovascular disease, hypertension, anxiety disorders, or take monoamine-modulating drugs.
  • Athletes: stimulants are prohibited in-competition; always verify status and avoid unlabeled stimulants.

Table of Contents

What is hordenine and how does it work?

Hordenine (chemical name N,N-dimethyltyramine) is a trace amine—part of a family of small molecules that resemble neurotransmitters. In foods, it appears in germinating barley and may be present in beer in microgram amounts. As a supplement ingredient, hordenine is typically included in “pre-workout” and “thermogenic” blends intended for energy and appetite control.

Mechanistically, several lines of preclinical research frame how hordenine may act:

  • Dopamine D2 receptor activity. In vitro studies identify hordenine as a dopamine D2 receptor agonist with biased signaling, meaning it may preferentially activate some intracellular pathways over others. This has been proposed to contribute to a subtle “reward” or motivation signal, although measured blood levels after dietary exposure are far lower than concentrations used in receptor assays.
  • Sympathomimetic profile. Hordenine belongs to the phenethylamine family (related to tyramine). Compounds in this class can indirectly increase norepinephrine signaling, producing transient increases in heart rate, blood pressure, and alertness. Whether hordenine meaningfully does this in humans at supplement-level doses is not well quantified.
  • Metabolism and half-life. Human kinetic data show rapid absorption, extensive phase-II metabolism (first sulfation, then glucuronidation), and short apparent half-life around an hour for free hordenine, with conjugated forms persisting longer. This fits the stimulant-like experience that—when it occurs—is typically brief.
  • Other exploratory biology. Cell experiments suggest anti-inflammatory signaling in immune models and effects on dermal papilla cells (related to hair biology). These findings are hypothesis-generating rather than definitive human evidence.

Taken together, hordenine looks like a short-acting, potentially stimulating trace amine with dopamine-receptor activity in vitro, rapid metabolism, and uncertain clinical relevance at real-world oral exposures. For everyday users, the key practical implication is that any perceived effect will likely be brief, variable, and highly individual, with a dose-response that is not well characterized and a safety profile that is not firmly established in rigorous human trials.

Back to top ↑

What benefits are actually supported?

Marketing claims for hordenine cluster around energy, focus, fat-loss, and mood. Here’s how those stack up against available evidence:

Energy and alertness.
From a pharmacology standpoint, a phenethylamine-like compound that can influence catecholamine pathways might create a sense of alertness. However, controlled human trials specifically measuring acute cognition, reaction time, or perceived energy after isolated hordenine ingestion are lacking. User reports exist, but these are subject to placebo effects and often involve multi-ingredient formulas (caffeine, synephrine, yohimbine), making it impossible to isolate hordenine’s contribution.

Weight management or “thermogenesis.”
No randomized trials have tested hordenine alone for body weight, fat mass, or energy expenditure. Extrapolations from related amines are not sufficient to claim efficacy. If any effect exists, it is likely small and short-lived, overshadowed by better-studied strategies (dietary protein targets, fiber intake, training load, sleep). For individuals sensitive to stimulants, even a small acute effect could be outweighed by side effects (jitters, palpitations).

Mood and motivation.
The D2 receptor hypothesis is intriguing, but dietary exposure studies show nanomolar plasma levels after beer consumption—likely below thresholds needed for robust receptor occupancy in the brain. Without direct clinical outcomes (scales of mood, motivation, or hedonic response) in trials of isolated hordenine, mood-related claims remain speculative.

Exercise performance.
There are no high-quality human trials (randomized, placebo-controlled, adequately powered) assessing hordenine for strength, endurance, sprint performance, or time-to-exhaustion. Most performance supplements that include hordenine also contain caffeine and other actives, which confound interpretation.

Other investigated actions.
Preclinical work explores anti-inflammatory and dermal cell effects. These data support further research, not current health claims. Don’t extrapolate mouse or cell results to humans without bridging evidence.

Bottom line: The evidence base is thin. If hordenine has benefits, they likely reflect brief stimulant-like effects in a subset of users at doses that may also increase side-effect risk. There is no established clinical benefit for fat-loss, cognition, or performance when hordenine is used alone.

Back to top ↑

How to use hordenine in practice?

Because there is no standardized therapeutic dose or clinically validated indication, “how to use” really means how to minimize risk if you still choose to try a product that lists hordenine on the label.

Forms you’ll see

  • Standalone capsules or powders claiming energy or appetite support.
  • Pre-workout blends combining hordenine with caffeine, synephrine, N-methyltyramine, rauwolscine/yohimbine, and nootropics (L-tyrosine, theobromine).
  • Fat-burner blends with green tea extract, capsaicin, and others.

Label transparency matters. Avoid proprietary blends that hide milligram amounts. Products should disclose exact hordenine content per serving and per day. Verify third-party testing when possible.

Timing tips (if you choose to use it)

  • Pre-exercise window: If a product is used at all, people typically take it 30–45 minutes before training, aligning with rapid oral absorption and short half-life.
  • Avoid late-day doses to reduce interference with sleep.
  • Cycle or limit frequency rather than daily use to reduce tolerance, though tolerance patterns are not well studied for hordenine specifically.

Stacking cautions

  • Do not stack with other stimulants (caffeine, synephrine, yohimbine) if you’re sensitive to increases in heart rate or blood pressure.
  • Do not combine with monoamine oxidase (MAO) inhibitors or drugs that substantially modulate catecholamines or serotonin (including some antidepressants).
  • Avoid with tyramine-rich diets if you use medications that alter monoamine metabolism, given theoretical interactions among trace amines.

Special populations

  • Athletes: In-competition stimulant rules are strict. Many stimulant-type ingredients trigger adverse findings—sometimes from contaminated products. If you are bound by anti-doping codes, the prudent choice is to avoid hordenine-containing products altogether and verify all supplements through your sport’s approved channels.
  • Medical conditions: Hypertension, arrhythmias, anxiety disorders, glaucoma, hyperthyroidism—avoid stimulant-like products.
  • Pregnancy/breastfeeding/under 18: Avoid due to insufficient safety data.

Practical alternative strategies

If your goal is energy or body composition, safer, better-validated tools exist: caffeine dosed at 1–3 mg/kg pre-exercise (for healthy adults), adequate protein (1.6–2.2 g/kg/day), fiber (≥25–38 g/day), creatine monohydrate (3–5 g/day), and structured training and sleep hygiene. These have stronger evidence than hordenine and a clearer risk-benefit profile.

Back to top ↑

Dosage, timing, and combinations

There is no medically established dosing range for hordenine. What follows summarizes observed exposures and guardrails to help you interpret product labels—not a recommendation to use hordenine.

What research exposures look like

  • Dietary exposure (beer): A small human kinetic study administering beer containing hordenine achieved ~0.075 mg/kg of hordenine, with peak free hordenine in blood in the nanomolar range within an hour and a short half-life (~53–66 minutes).
  • In vitro permeability: Caco-2 and blood-brain barrier models show relatively rapid transport of hordenine and formation of hordenine sulfate, hinting at quick uptake but also quick metabolism and possible efflux transport.
  • Animal studies: In mouse models interrogating inflammation, 10–15 mg/kg oral doses were explored without evident acute toxicity in the specific experimental context.

Interpreting supplement labels

Commercial products sometimes list 20–100 mg per serving or bury the amount in a proprietary blend. Because kinetic data suggest a short half-life and brisk conjugation, higher milligram labels won’t necessarily translate to sustained central effects—and they may increase side-effect risk.

If someone chooses to proceed despite limited safety data

  • Start low (closest to the minimum labeled amount), use infrequently, and do not exceed the label.
  • Do not exceed one serving/day when other stimulants (including coffee) are in the routine.
  • Avoid “stacking” with synephrine, yohimbine, high-dose caffeine, or other phenethylamines.
  • Build in off-days to reduce tolerance and monitor blood pressure and heart rate during the first uses.
  • Stop immediately if you feel palpitations, chest pain, severe anxiety, or dizziness.

Combinations sometimes seen—and safer pivots

  • Hordenine + caffeine: Common in pre-workouts; increases cardiovascular strain. Safer pivot: caffeine alone at evidence-based doses.
  • Hordenine + synephrine/yohimbine: Raises risk of anxiety, hypertension, and adverse events. Safer pivot: structured nutrition and training, avoid the stack.
  • Hordenine + nootropics (L-tyrosine, theanine): While non-stimulant amino acids look safer, adding hordenine still complicates risk management; consider nootropics without stimulants.

Timing recap

Given the short half-life, timing doses (if used) 30–45 minutes pre-exercise aligns with peak availability. Avoid evenings. Hydrate well and do not combine with alcohol.

Back to top ↑

Side effects, risks, and who should avoid it

Commonly reported stimulant-type effects (especially when combined with other stimulants):

  • Jitters, restlessness, tremor
  • Palpitations, elevated heart rate
  • Headache, increased blood pressure
  • Anxiety, irritability, insomnia
  • Nausea or GI upset

Less common but more serious concerns (seek medical care if these occur):

  • Chest pain, severe hypertension, fainting
  • Severe anxiety or panic
  • Arrhythmias

Drug and condition interactions

  • Antidepressants and mood medicines: Interactions are theoretical but concerning with monoamine oxidase inhibitors and other drugs that alter serotonin, dopamine, or norepinephrine (including certain tricyclics, SNRIs, and stimulants for ADHD).
  • Hypertension, heart disease, arrhythmias: Avoid stimulant-like supplements entirely.
  • Glaucoma, hyperthyroidism: Stimulants may worsen symptoms—avoid.
  • Pregnancy, breastfeeding, pediatrics: Insufficient safety data—avoid.

Athletes and compliance

Anti-doping rules classify stimulants as prohibited in competition. Even when a particular substance isn’t named, “related substances” and designer analogs can trigger adverse findings. Supplement contamination is a persistent risk. If you compete under an anti-doping code, the conservative position is to avoid hordenine-containing products and to use only batch-tested, verified supplements vetted by your sport.

Quality and labeling realities

Supplement surveys frequently identify label inaccuracies and undeclared actives in stimulant categories. Choose products with third-party certification, avoid proprietary blends, and be skeptical of outsized claims.

When to stop and seek help

  • Marked blood pressure rise or persistent tachycardia
  • Chest pain, breathlessness, syncope
  • Severe anxiety, agitation, or insomnia that persists beyond several hours

Safer alternatives by goal

  • Energy for training: Caffeine (1–3 mg/kg), carbohydrate timing, creatine.
  • Weight management: Protein targets, fiber intake, resistance training, sleep.
  • Focus: Sleep optimization, task batching, hydration, and (if appropriate) low-dose caffeine with theanine.

Back to top ↑

Evidence check: what the science says

What we know with reasonable confidence

  • Human kinetics exist. After oral exposure from beer, hordenine appears in plasma quickly, peaks within an hour, and is extensively conjugated (sulfate, then glucuronide). The free form clears with a half-life around an hour, while conjugates persist longer. Urinary excretion within the first day accounts for a minority of the dose, consistent with extensive metabolism.
  • Cell transport models show relatively efficient crossing of intestinal epithelium and model blood-brain barriers, but also indicate efflux processes and rapid formation of sulfate conjugates—factors likely to limit central nervous system exposure at typical oral doses.
  • Preclinical effects include anti-inflammatory signaling in specific mouse models and cellular effects on dermal papilla cells. These results justify further study but do not establish clinical benefits in humans.

What remains uncertain or unsupported

  • Clinical efficacy for fat-loss, performance, or cognition is unproven. There are no robust randomized controlled trials of isolated hordenine in healthy humans addressing these outcomes.
  • Long-term safety data in humans are lacking. Most information comes from short exposures, animal studies, or indirect inference from related compounds.
  • Dose-response is unknown. Label doses vary widely, and there is no consensus on effective or safe chronic intake.

How to interpret all this as a consumer or clinician

  • If someone perceives benefit from a product containing hordenine, it’s most plausibly a short, stimulant-like effect which might also be achievable with better-characterized ingredients (e.g., caffeine) at lower risk.
  • For athletes subject to anti-doping rules, avoidance is rational due to stimulant class restrictions and contamination risk.
  • For individuals with cardiovascular risk or psychiatric sensitivity, the risk-benefit balance favors non-stimulant strategies for energy or weight control.

Research priorities

  • Controlled human trials on hemodynamic responses, cognitive performance, and exercise outcomes using isolated hordenine.
  • Pharmacokinetic-pharmacodynamic modeling at supplement-relevant doses, including the role of conjugated metabolites.
  • Safety and interaction studies with common co-ingredients (caffeine, synephrine).
  • Doping risk assessments using contamination-screened products with blinded testing.

Back to top ↑

References

Disclaimer

This article provides general information about hordenine for educational purposes. It is not medical advice and does not replace consultation with a qualified healthcare professional. Do not start, stop, or change any supplement or medication based on this content. Hordenine’s long-term safety and effective dosing are not established; many products combine multiple stimulants, which can increase risk. Athletes must verify all supplements against their sport’s current anti-doping rules.

If you found this guide useful, consider sharing it with friends or colleagues on Facebook, X (formerly Twitter), or any platform you prefer, and follow us on social media. Your support helps us continue producing careful, evidence-based articles.

RELATED ARTICLESMORE FROM AUTHOR